This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2025 Oct 21;334(15):1333-1335.

doi: 10.1001/jama.2025.10869.

Are Psychedelic Agents Ready for Prime Time as Stand-Alone Treatments?

Claudio N Soares^{1

2}

Affiliations

Affiliations

¹ Psychiatry, Queen's University, Kingston, Ontario, Canada.
² Centre for Psychedelic Health and Research, Queen's University and Providence Care Hospital, Kingston, Ontario, Canada.

PMID: 40906492
DOI: 10.1001/jama.2025.10869

Comment

Are Psychedelic Agents Ready for Prime Time as Stand-Alone Treatments?

Claudio N Soares. JAMA. 2025.

. 2025 Oct 21;334(15):1333-1335.

doi: 10.1001/jama.2025.10869.

Author

Claudio N Soares^{1

2}

Affiliations

¹ Psychiatry, Queen's University, Kingston, Ontario, Canada.
² Centre for Psychedelic Health and Research, Queen's University and Providence Care Hospital, Kingston, Ontario, Canada.

PMID: 40906492
DOI: 10.1001/jama.2025.10869

No abstract available

PubMed Disclaimer

Comment on

Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder: A Randomized Clinical Trial.
Robison R, Barrow R, Conant C, Foster E, Freedman JM, Jacobsen PL, Jemison J, Karas SM, Karlin DR, Solomon TM, Halperin Wernli M, Fava M. Robison R, et al. JAMA. 2025 Oct 21;334(15):1358-1372. doi: 10.1001/jama.2025.13481. JAMA. 2025. PMID: 40906494 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems